UPClytics
Alle Fälle anzeigen

UPC APP 8962/2025

·EP2129425: EMBOLIC PROTECTION DEVICE

Verfahrensdetails
Status
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien
Kläger
Vertreter: Thure Schubert
Beklagte
Vertreter: Sabine Agé
Division
Munich LD
Richter
Technology
Pharmaceutical & Medical
Sprache
Erste Entscheidung
16. Apr. 2025
Entscheidungen
  • 2025-04-16
    Generic application

    The Munich Local Division judge-rapporteur ordered AorticLab srl (defendant/counterclaimant) to provide security for costs in favour of the claimant Emboline Inc., finding that AorticLab's own statement that it would be driven to insolvency by an injunction demonstrated a legitimate and real concern that a costs order might not be recoverable.

    Rechtsfragen:Security for costs (R. 158 RoP, Art. 69(4) UPCA)Entitlement of defendant who files counterclaim to seek securityFinancial position giving rise to concern about cost recovery
Dokumente
  • 0735B5EB42BAF2E815E54BE636B6E858_en.pdf2025-04-16EN